0001834488-25-000152
SEC filingNotes section contains no numeric data; only note titles provided.
Operating cash flow (CFO) for the six months ended June 30, 2025 was $47.9 million, a decrease of 9% from $52.6 million in the same period of 2024. This decline suggests a slight weakening in cash generation relative to the prior year. Capital expenditures (capex) were $4.4 million, representing a capex intensity of approximately 9.2% of CFO, indicating a moderate investment level. Implied free cash flow (CFO minus capex) was $43.5 million, providing ample coverage for the reported zero share repurchases and dividends. No working capital swings or one-time items were explicitly noted in the provided excerpt, but the overall cash flow profile remains healthy with no capital returns to shareholders during the period.